Literature DB >> 19799807

[Comment for the Chinese 2008 staging system for nasopharyngeal carcinoma].

Ying Sun1, Jun Ma.   

Abstract

The advantages of the Chinese 2008 staging system for nasopharyngeal carcinoma included as follows: 1.Application of MRI as the major staging means; discard of the subjective factors. 2.Adoption of some new independent predictor such as metastatic retropharyngeal lymph nodes and RTOG cervical levels. 3.Simplification of the T category. 4.Categorization of N and clinical substage can distinct the risk of distant metastasis and overall survival. All these changes adapted to the modern diagnosis and treatment pattern with a higher degree of practicality. Therefore, developing a prospective, multicenter clinical verification of the existing standards, thereby correcting itself, fulfill the developmental and scientific principles. It may improve as follows: 1.The definition of anatomical structure is restrictive such as nasal cavity and oropharynx, and the expression of masticator space is not intuitive. 2.Proof of evidence-based medicine for the size of lymph nodes included in the N category is insufficient. 3.The risk of local recurrence between the subgroups of T category was not significant. 4.Different definition of the index such as oropharynx and cervical level between the sixth edition UICC / AJCC staging system and the current system will hinder the international exchange of experience and information.

Entities:  

Mesh:

Year:  2009        PMID: 19799807     DOI: 10.5732/cjc.009.10448

Source DB:  PubMed          Journal:  Ai Zheng


  5 in total

1.  miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.

Authors:  Min Deng; Qiurong Ye; Zailong Qin; Ying Zheng; Wei He; Hailin Tang; Yanhong Zhou; Wei Xiong; Ming Zhou; Xiaoling Li; Qun Yan; Jian Ma; Guiyuan Li
Journal:  Tumour Biol       Date:  2013-03-13

2.  An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.

Authors:  Zhaohui Luo; Liyang Zhang; Zheng Li; Xiayu Li; Gang Li; Haibo Yu; Chen Jiang; Yafei Dai; Xiaofang Guo; Juanjuan Xiang; Guiyuan Li
Journal:  BMC Med Genomics       Date:  2012-01-19       Impact factor: 3.063

3.  A new T classification based on masticator space involvement in nasopharyngeal carcinoma: a study of 742 cases with magnetic resonance imaging.

Authors:  Dong-Hua Luo; Jing Yang; Hui-Zhi Qiu; Ting Shen; Qiu-Yan Chen; Pei-Yu Huang; Rui Sun; Chao-Nan Qian; Hai-Qiang Mai; Xiang Guo; Hao-Yuan Mo
Journal:  BMC Cancer       Date:  2014-09-04       Impact factor: 4.430

4.  Locoregional extension patterns of nasopharyngeal carcinoma and suggestions for clinical target volume delineation.

Authors:  Wen-Fei Li; Ying Sun; Mo Chen; Ling-Long Tang; Li-Zhi Liu; Yan-Ping Mao; Lei Chen; Guan-Qun Zhou; Li Li; Jun Ma
Journal:  Chin J Cancer       Date:  2012-08-02

5.  MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma.

Authors:  Man Niu; Dan Gao; Qiuyuan Wen; Pingpin Wei; Suming Pan; Cijun Shuai; Huiling Ma; Juanjuan Xiang; Zheng Li; Songqing Fan; Guiyuan Li; Shuping Peng
Journal:  BMC Cancer       Date:  2016-03-15       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.